PA-EXONE-CO.
9.11.2021 14:32:09 CET | Business Wire | Press release
The ExOne Company (Nasdaq: XONE), the global leader in industrial sand and metal 3D printers using binder jetting technology, today announced that global manufacturing innovation leader Siemens is the first of several customers to place an advance purchase for the InnoventPro 3L metal 3D printer.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211109005404/en/
The InnoventPro is the world’s most advanced entry-level model for metal binder jetting — designed to take the easy-to-use features of the popular Innovent+ with patented Triple ACT advanced compaction technology and offer them with a bigger build area and the best speed and cutting-edge technology features of ExOne’s production-ready printers, such as the X1 25Pro® and X1 160Pro™.
The InnoventPro is slated to be on display for the first time in ExOne’s booth in Hall 12.0, Booth D69 at Formnext 2021 from Nov. 16-19 in Frankfurt, Germany. The machine is available for early-access machine customers in the first half of 2022, with broad availability to follow.
The InnoventPro features Siemens controls, which integrate with the printer drives, motors, sensors, as well as Siemens MindSphere IoT operating system, which powers ExOne’s Scout machine monitoring and analysis app.
Siemens will use the InnoventPro at its Charlotte Advanced Technology Collaboration Hub (CATCH) located in Charlotte, North Carolina to develop materials and processes before taking them to scale on the X1 160Pro.
“We’re very excited to feature the InnoventPro in our Technology Collaboration Hub, and we look forward to demonstrating how to integrate advanced additive manufacturing systems such as the InnoventPro into our end-to-end Digital Thread,” said Tim Bell, Head of Additive Manufacturing, Siemens Industry, Inc. The CATCH facility will leverage Siemens advanced hardware automation and software tools to continue the industrialization of additive manufacturing.
“ExOne is proud to continue offering Siemens technologies in our production-ready metal binder jetting systems, and we’re delighted that Siemens has purchased our new InnoventPro for its own manufacturing use,” said John Hartner, ExOne’s CEO. “Siemens technology continues to deliver important integration value to our production customers, and we’re confident our printer will deliver important manufacturing value to their operations as well.”
InnoventPro Feature Highlights
The affordable new InnoventPro is an all-new package built from the ground up that gives binder jetting customers the most advanced entry-level system on the market in a 3-liter build area of 125 x 220 x 100 mm. Features include:
- Triple ACT advanced compaction technology for precision dispensing, spreading, and compacting of ultra-fine MIM powders, delivering the industry-leading density, accuracy and repeatability that was proven on the Innovent+
- Now packaged with the same faster, smarter, recirculating printhead modules that come standard on ExOne production printers, enabling easy scalability to larger models
- The new printhead will be capable of speeds topping 700 cc/hour on the InnoventPro and printing a new class of patented NanoFuse™ binders embedded with nanoparticles to improve part quality and simplify sintering
- An innovative new comprehensive powder containment system, featuring the ergonomic X1 Powder Grip™ loading system, delivers ease-of-use and improved cleanliness
- Siemens MindSphere powers ExOne’s Scout machine monitoring and analysis app, part of ExOne’s strategy to surround its printers with a complete digital workflow. Scout is available today in the Apple App Store and on Google Play for use with ExOne production sand and metal 3D printers
The InnoventPro was designed by ExOne’s experienced binder jet engineering team based in Pittsburgh, Pennsylvania, and Gersthofen, Germany, with final manufacturing and assembly done in the United States.
Learn more about the InnoventPro at exone.com/innoventpro .
About ExOne
ExOne (Nasdaq: XONE) is the pioneer and global leader in binder jet 3D printing technology. Since 1995, we’ve been on a mission to deliver powerful 3D printers that solve the toughest problems and enable world-changing innovations. Our 3D printing systems quickly transform powder materials — including metals, ceramics, composites and sand — into precision parts, metalcasting molds and cores, and innovative tooling solutions. Industrial customers use our technology to save time and money, reduce waste, improve their manufacturing flexibility, and deliver designs and products that were once impossible. As home to the world’s leading team of binder jetting experts, ExOne also provides specialized 3D printing services, including on-demand production of mission-critical parts, as well as engineering and design consulting. Learn more about ExOne at www.exone.com or on Twitter at @ExOneCo. We invite you to join with us to #MakeMetalGreen™.
About Siemens Digital Industries
Siemens Digital Industries (DI) is an innovation leader in automation and digitalization. Closely collaborating with partners and customers, DI drives the digital transformation in the process and discrete industries. With its Digital Enterprise portfolio, DI provides companies of all sizes with an end-to-end set of products, solutions and services to integrate and digitalize the entire value chain. Optimized for the specific needs of each industry, DI’s unique portfolio supports customers to achieve greater productivity and flexibility. DI is constantly adding innovations to its portfolio to integrate cutting-edge future technologies. Siemens Digital Industries has its global headquarters in Nuremberg, Germany, and has around 75,000 employees internationally.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211109005404/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
HTEC Research: Only One in Three Healthcare Organizations is Ready to Scale AI28.4.2026 15:22:00 CEST | Press release
Healthcare and life sciences leaders are advancing AI with caution—fragmentation, capability gaps, and execution challenges are slowing enterprise-wide impact AI is already embedded across healthcare and life sciences. Most organizations are deploying it, and confidence in its potential is high. Yet for many, the real challenge is only just beginning. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428872907/en/ HTEC, a global AI‑first provider of software and hardware design and engineering services, today released new research based on a global survey of 253 C-level HLS executives across the United States, United Kingdom, Germany, Spain, Saudi Arabia, and the UAE. AI is already embedded across healthcare and life sciences. Most organizations are deploying AI, and confidence in its potential is high. Yet for many, the real challenge is only just beginning. HTEC, a global AI‑first provider of software and hardware design a
JPMorganChase Named First-Ever Global Banking Partner of the Olympic Games28.4.2026 15:00:00 CEST | Press release
International Olympic Committee and JPMorganChase Announce Landmark Global Olympic Partnership The International Olympic Committee (IOC) and JPMorganChase today announced a landmark Worldwide Olympic Partnership, making JPMorganChase the first Global Banking Partner in Olympic history. The partnership includes the Los Angeles 2028 Olympic and Paralympic Games (LA28 Games) and the French Alps 2030 Olympic and Paralympic Winter Games. The firm has also reached an agreement with LA28 to become the Official Bank of Team USA and LA28, and a Founding Partner of the LA28 Games. The partnership reflects a shared commitment to ambition and excellence, and places athletes and communities at its core. Kirsty Coventry, President of the IOC, commented: “JPMorganChase is the first Global Partner from the banking sector in Olympic history, and we are proud to welcome them to the Worldwide Olympic Partner programme. This partnership reflects our shared values of ambition, excellence and will support t
BlueSnap, Powered by Payroc, Launches Local Acquiring in New Zealand to Boost Approval Rates and Reduce Cross-Border Costs28.4.2026 15:00:00 CEST | Press release
BlueSnap, powered by Payroc, today announced the availability of local acquiring in New Zealand, expanding its global payment orchestration capabilities and enabling businesses to process transactions domestically. Local acquiring allows businesses with a legal entity in New Zealand to process payments through domestic acquiring banks rather than routing transactions cross-border. This helps increase authorization rates, reduce payment failures, and lower transaction costs, critical factors for businesses selling into the region. Why Local Acquiring in New Zealand Matters For B2B and B2C businesses operating globally, cross-border payments often lead to higher fees and lower approval rates. Building local acquiring infrastructure independently requires managing multiple bank relationships, compliance, and integrations, making it costly and complex. BlueSnap simplifies this by providing local acquiring through a single platform, allowing businesses with a legal entity in New Zealand to
Vensica Medical Receives FDA IND Clearance to Initiate Phase 2 Study of ViXe, Its Needle-Free Xeomin® Delivery System for Overactive Bladder28.4.2026 14:42:00 CEST | Press release
Vensica Medical, a clinical-stage company developing needle-free therapeutic delivery solutions for urologic diseases, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s Investigational New Drug (IND) application to initiate a Phase 2 clinical trial of ViXe. The study will evaluate the Vibe® ultrasound-based, needle-free drug delivery system in combination with Xeomin® (incobotulinumtoxinA) for the treatment of overactive bladder (OAB). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260414145279/en/ Avner Geva, Cofounder, CEO (left), and Avi Eftel, Cofounder, CTO (right) Overactive bladder affects an estimated 33 million adults in the United States and is characterized by urinary urgency, frequency, and incontinence. While intravesical botulinum toxin injection is an established second-line treatment, the invasive procedure limits patient access and acceptance. The ViXe program is desi
Printing the Future of Oncology: CTIBIOTECH Invests €3M and Secures €1.25M from France 2030 to Revolutionize Personalized Cancer Care28.4.2026 14:28:00 CEST | Press release
CTIBIOTECH™, a leading innovator in advanced human tissue engineering, proudly announces CTIONCOTEST™ platform is awarded Major Bpifrance Funding to Industrialize 3D Bioprinted Cancer Models CTIBIOTECH Announces the CTIONCOTEST ™ Project to Revolutionize Cancer Research with 3D Bioprinted Microtumors, Backed by France 2030 and Bpifrance This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260428242352/en/ The CTIONCOTEST™ platform by CTIBIOTECH is an innovative 3D bioprinting technology that revolutionizes preclinical cancer research . It provides an automated, industrial-scale process to produce high-throughput, patient-specific human "microtumors" directly from primary tumor cells . Designed to tackle the 95% clinical failure rate of new cancer drugs, it faithfully replicates the complex tumor microenvironment, including critical hypoxic and necrotic zones . Targeting high-mortality breast, colon, and pancreatic cancers, the pla
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom